Diseases

ViraCyte, LLC announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for Viralym-C, ViraCyte's T cell immunotherapy product designed to treat…
Read More...

Hutchison China MediTech Limited announces that it has initiated a Phase I trial of its novel spleen tyrosine kinase (“Syk”) inhibitor, HMPL-523, in patients with hematological…
Read More...

Enzyvant, a biopharmaceutical company focused on developing innovative treatments for patients with rare diseases, today announced entering into an exclusive worldwide licensing…
Read More...

Takeda Pharmaceutical Company Limited and PvP Biologics, Inc. announced a global agreement for the development of KumaMax, a novel enzyme designed to break down the immune-reactive…
Read More...

Marinus Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the development of innovative therapeutics to treat epilepsy and neuropsychiatric disorders, today announced that…
Read More...

Tillotts Pharma has introduced a new advanced enteric coating for solid dosage forms at this year's annual meeting of the American Association of Pharmaceutical Scientists. The…
Read More...

IBM announced that many IBM U.S. employees fighting cancer will be able to tap into Watson for insights into their cancer treatment as well as potential clinical trial options. Through…
Read More...

As one of medicine’s largest challenges, viral infections often escape vaccines due to their natural ability to mutate rapidly and develop drug resistance easily. Many viruses, such as…
Read More...

Pathcore and a team of investigators from the US and Canada have received an award from National Cancer Institute (NCI), a division of the National Institutes of Health (NIH), to…
Read More...